December 01, 2011 Archives - Page 2 of 4 - Clinical Advisor

Print Issue: December 01, 2011

Fentanyl nasal spray manages cancer pain

Fentanyl nasal spray is indicated for breakthrough pain in opioid-tolerant patients who are already receiving and tolerant to continuous opioid therapy for underlying persistent cancer pain.

Next post in Dermatologic Look-Alikes